Nippon India Pharma Fund

Q: What are the returns of this mutual fund scheme?

The Nippon India Pharma Fund is a 21 yrs 5 m old fund and has delivered average annual returns of 20.24% since inception. Nippon India Pharma Fund Returns 1-Year 3-Year 5-Year 10-Year Since Inception 2.0% 21.83% 18.23% 12.7% 20.24%

Q: How much does this mutual fund charge as expense ratio?

The Nippon India Pharma Fund has an expense ratio of 1.82% , representing the annual cost of managing and operating the fund. This fee is deducted from the fund's AUM while declaring the daily NAV, reducing investor returns.

NAV as of Oct 20, 2025	Returns since inception	ET Money Rank	AUM (Fund size)
₹516.9486+0.62% 1 day change	20.24% p.a.	App exclusive #NA View Ranked Funds	₹8,114 Cr

Historical NAV & returns

NAV: ₹516.9486 as on Oct 20, 2025

This fund Category average

Nippon India Pharma Fund overview

AUM (Fund size)	₹8,114 Cr
Exit load	1.0% Exit load of 1% if redeemed within 1 month.!
Lock-in Period	Nil
Age	21 yrs 5 m since May 10, 2004
Benchmark	BSE Healthcare TRI
Min. investment	SIP: ₹500 & Lumpsum: ₹1000
Expense ratio	1.82% as on Sep 30, 2025
Plan type	Regular
Risk	Very High
Short term capital gains (STCG)	Returns taxed at 20% if you redeem before 1 year
Long term capital gains (LTCG)	After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%

Nippon India Pharma Fund Returns calculator

Investment type

Monthly investment

₹ 10,000

Investment period

Lumpsum investment

₹1 lakh

Investment period

Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully. Past performance is not an indicator of future returns.

Total investment ₹ 12 lakh
Profit ₹12 lakhs
Total corpus ₹1 lakh
Absolute return 52.69%

Trailing returns as on Oct 25, 2025

Period	This fund	Category average
1 Month	1.55%	2.15%
3 Months	-2.59%	-0.73%
6 Months	4.62%	7.45%
1 Year	2.0%	4.27%
2 Years	23.18%	26.67%
3 Years	21.83%	23.14%
4 Years	14.54%	15.45%
5 Years	18.23%	18.13%
7 Years	19.57%	20.78%
10 Years	12.7%	11.61%

View returns in detail

Asset allocationas on Sep 30, 2025

Large Cap 48.72%

Mid Cap 20.59%

Small Cap 30.13%

Other Cap 0%

Top holdings

Sun Pharmaceutical Industries Ltd.12.29%

Lupin Ltd.7.26%

Divi's Laboratories Ltd.7.01%

Cipla Ltd.6.48%

Top sectors

Healthcare 99.44000000000001%

Credit quality

Bifurcation by Credit Quality is not available for this fund

Top Debt Holdings

Bifurcation by Holding is not available for this fund

Allocation by Instruments

Repo 0.46%

Net Current Assets 0.1%

Margin Money 0.00264371%

Other Holdings

Others 0.1%

Detailed portfolio analysis

Peer comparison

Fund name	1M	6M	1Y	3Y	5Y	10Y
Nippon India Pharma Fund	1.55%	4.62%	2.0%	21.83%	18.23%	12.7%
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund	1.8%	9.49%	7.55%	27.92%	20.98%	15.16%
SBI Healthcare Opportunities Fund	2.93%	5.7%	7.57%	25.5%	20.14%	11.0%
DSP Healthcare Fund	2.27%	6.86%	0.02%	22.71%	18.11%	14.77%
Tata India Pharma & Healthcare Fund	1.98%	6.5%	2.98%	22.6%	18.43%	11.98%

Fund name	Std. deviation	Beta	Sharpe	Sortino
Nippon India Pharma Fund	15.22	0.91	0.9	1.39
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund	15.66	0.95	1.2	1.74
SBI Healthcare Opportunities Fund	14.07	0.84	1.19	1.86
DSP Healthcare Fund	14.67	0.84	1.03	1.8
Tata India Pharma & Healthcare Fund	16.05	0.97	0.92	1.47

Fund name	ETM Rank	AUM	Fund age	Expense ratio
Nippon India Pharma Fund	N.A.	8,114 Cr	21 yrs 5 m	1.82%
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund	N.A.	6,227 Cr	7 yrs 4 m	1.87%
SBI Healthcare Opportunities Fund	N.A.	3,933 Cr	26 yrs 4 m	1.93%
DSP Healthcare Fund	N.A.	3,074 Cr	6 yrs 11 m	1.93%
Tata India Pharma & Healthcare Fund	N.A.	1,296 Cr	9 yrs 10 m	2.1%

View all Sectoral-pharma funds

Key risk & return ratios Compared to other funds in the category

Alpha	-1.0 vs. 5.44 Underperformed at beating benchmark
Sharpe	0.9 vs. 3.41 Poor risk-adjusted returns
Beta	0.91 vs. 0.7 More sensitive to market's ups & downs
Standard deviation	15.22 vs. 9.13 More volatile performance

Compare Nippon India Pharma Fund in detail with

About this fund

About Nippon India Pharma Fund

Nippon India Pharma Fund is a Sectoral-Pharma mutual fund scheme from Nippon India Mutual Fund. This fund has been in existence for 21 yrs 5 m, having been launched on 10/05/2004. Nippon India Pharma Fund has ₹8,114 Crores worth of assets under management (AUM) as on 30/09/2025 and is medium-sized fund of its category. The latest Net Asset Value (NAV) of Nippon India Pharma Fund as of 20/10/2025 is ₹516.95. The fund has an expense ratio of 1.82%, which is higher than what most other Sectoral-pharma funds charge.

Nippon India Pharma Fund returns of last 1-year are -1.16%. Since launch, it has delivered 20.26% average annual returns. The fund has doubled the money invested in it every 4 yrs.
Nippon India Pharma Fund scheme's ability to deliver returns consistently is in-line with most funds of its category. Its ability to control losses in a falling market is average.
The fund has the majority of its money invested in Healthcare sectors. It has taken less exposure in Healthcare sectors compared to other funds in the category.
The fund's top 5 holdings are in Sun Pharmaceutical Industries Ltd., Lupin Ltd., Divi's Laboratories Ltd., Cipla Ltd., Apollo Hospitals Enterprise Ltd..

...

Fund AUM	8,114 Cr as on Sep 30, 2025
Scheme document	View Scheme Document

Fund managers

Sailesh Raj Bhan

Mr. Bhan is an MBA (Finance) and CFA. Prior to joining Nippon India Mutual Fund, he has worked with Emkay Share & Stock Broker Pvt. Ltd, Shah & Sequeira Invst. Pvt. Ltd, ICFAI- Securities Research Center Analyst - Equity Research.

Investment objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Nippon India Mutual Fund details

No. of schemes	71 view all schemes
Total AUM	6,63,684 Cr as on Sep 30, 2025
Address	4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W), Mumbai, 400013

More funds from Nippon India Mutual Fund

Fund name	ETM Rank	AUM	1Y	5Y
Nippon India Small Cap Fund	N.A.	66,136 Cr	0.27%	32.7%
Nippon India Power & Infra Fund	N.A.	7,325 Cr	2.92%	32.06%
Nippon India Multi Cap Fund	N.A.	47,294 Cr	5.84%	30.37%
Nippon India Growth Mid Cap Fund	N.A.	39,329 Cr	6.4%	29.58%
Nippon India Nifty Smallcap 250 Index Fund	N.A.	2,563 Cr	0.61%	26.71%
Nippon India Value Fund	N.A.	8,791 Cr	5.43%	26.07%

See all Equity funds from this AMC

Frequently asked questions

What is the current NAV of Nippon India Pharma Fund?

The current Net Asset Value (NAV) of the Nippon India Pharma Fund plan is approximately ₹516.9486 as of Oct 20, 2025.

What are the returns of this mutual fund scheme?

The Nippon India Pharma Fund is a 21 yrs 5 m old fund and has delivered average annual returns of 20.24% since inception.

Nippon India Pharma Fund Returns

1-Year	3-Year	5-Year	10-Year	Since Inception
2.0%	21.83%	18.23%	12.7%	20.24%

How much does this mutual fund charge as expense ratio?

The Nippon India Pharma Fund has an expense ratio of 1.82%, representing the annual cost of managing and operating the fund. This fee is deducted from the fund's AUM while declaring the daily NAV, reducing investor returns.

What is the AUM or fund size of this mutual fund?

The Nippon India Pharma Fund currently has assets under management (AUM) or fund size valued at approximately 8,114 Cr as on Sep 30, 2025.

What are the top stock holdings of Nippon India Pharma Fund?

The Nippon India Pharma Fund has invested the majority of its money in the stocks of the following companies -

Company	Percentage of Portfolio
Sun Pharmaceutical Industries Ltd.	12.29%
Lupin Ltd.	7.26%
Divi's Laboratories Ltd.	7.01%
Cipla Ltd.	6.48%
Apollo Hospitals Enterprise Ltd.	5.92%
Dr. Reddy's Laboratories Ltd.	5.91%
Vijaya Diagnostic Centre Ltd.	3.56%
Medplus Health Services Ltd.	3.39%
Gland Pharma Ltd.	3.24%
Glaxosmithkline Pharmaceuticals Ltd.	2.99%

What are the top sectors Nippon India Pharma Fund has invested in?

The Nippon India Pharma Fund has primarily invested in the following sectors

Sector	Percentage of Portfolio
Healthcare	99.44000000000001%

What is risk level of Nippon India Pharma Fund?

This is a Sectoral-pharma fund comes with Very High risk.

Is there any lock-in period in this mutual fund?

No, this fund does not have any lock-in period.

How can I redeem my investments in Nippon India Pharma Fund?

Redeeming your investments in the Nippon India Pharma Fund is simple. If you have invested via ET Money, just log in to the app, go to the holdings section, and submit the redemption request.

If you have invested from anywhere else, you can go to the fund house website and put a request through it.

ET Money rank

App exclusive

in Sectoral-Pharma

#NA

Return Outperformance: This fund has generated highest return amongst Sectoral-Pharma funds in the last 10 Years.
Return/Risk: The fund is performing poorly than its category.
Exit Load: Exit load of 1% if redeemed within 1 month.